These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30017996)

  • 1. Creation of a drug-sensitive reporter strain of Pseudomonas aeruginosa as a tool for the rapid screening of antimicrobial products.
    Engelberg R; Danielson A; Wang S; Singh M; Wai A; Sorensen J; Duan K; Hausner G; Kumar A
    J Microbiol Methods; 2018 Sep; 152():1-6. PubMed ID: 30017996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coprophilous fungi: antibiotic discovery and functions in an underexplored arena of microbial defensive mutualism.
    Bills GF; Gloer JB; An Z
    Curr Opin Microbiol; 2013 Oct; 16(5):549-65. PubMed ID: 23978412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioluminescent whole-cell reporter gene assays as screening tools in the identification of antimicrobial natural product extracts.
    Nybond S; Karp M; Yrjönen T; Tammela P
    J Microbiol Methods; 2015 Jul; 114():54-6. PubMed ID: 25937087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility Profile of Ceftolozane/Tazobactam and Other Parenteral Antimicrobials Against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa From US Hospitals.
    Sutherland CA; Nicolau DP
    Clin Ther; 2015 Jul; 37(7):1564-71. PubMed ID: 26088525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for beta-lactam antibiotics using a mutant of Pseudomonas aeruginosa.
    Kitano K; Nara K; Nakao Y
    Jpn J Antibiot; 1977 Dec; 30 Suppl():239-45. PubMed ID: 418199
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of a Potential Inhibitor Targeting MurC Ligase of the Drug Resistant Pseudomonas aeruginosa Strain through Structure-Based Virtual Screening Approach and In Vitro Assay.
    Messaoudi A; Zoghlami M; Basharat Z; Sadfi-Zouaoui N
    Curr Pharm Biotechnol; 2019; 20(14):1203-1212. PubMed ID: 31333120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dictyostelium discoideum as a surrogate host-microbe model for antivirulence screening in Pseudomonas aeruginosa PAO1.
    Bravo-Toncio C; Álvarez JA; Campos F; Ortíz-Severín J; Varas M; Cabrera R; Lagos CF; Chávez FP
    Int J Antimicrob Agents; 2016 May; 47(5):403-9. PubMed ID: 27066943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial and anti-Quorum Sensing activities of selected medicinal plants of Ethiopia: Implication for development of potent antimicrobial agents.
    Bacha K; Tariku Y; Gebreyesus F; Zerihun S; Mohammed A; Weiland-Bräuer N; Schmitz RA; Mulat M
    BMC Microbiol; 2016 Jul; 16(1):139. PubMed ID: 27400878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotics from neglected bacterial sources.
    Pidot SJ; Coyne S; Kloss F; Hertweck C
    Int J Med Microbiol; 2014 Jan; 304(1):14-22. PubMed ID: 24120363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary Metabolites of Mangrove-Associated Strains of Talaromyces.
    Nicoletti R; Salvatore MM; Andolfi A
    Mar Drugs; 2018 Jan; 16(1):. PubMed ID: 29316607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial evaluation of selected naturally occurring oxyprenylated secondary metabolites.
    Di Giulio M; Genovese S; Fiorito S; Epifano F; Nostro A; Cellini L
    Nat Prod Res; 2016 Aug; 30(16):1870-4. PubMed ID: 27498831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The search for new sporicidal agents for medical use: where are we?
    Piktel E; Pogoda K; Savage PB; Bucki R
    Future Microbiol; 2017 Jul; 12():735-737. PubMed ID: 28593804
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolomic tools used in marine natural product drug discovery.
    Stuart KA; Welsh K; Walker MC; Edrada-Ebel R
    Expert Opin Drug Discov; 2020 Apr; 15(4):499-522. PubMed ID: 32026730
    [No Abstract]   [Full Text] [Related]  

  • 14. Antimicrobial resistance of 3 types of gram-negative bacteria isolated from hospital surfaces and the hands of health care workers.
    Wang HP; Zhang HJ; Liu J; Dong Q; Duan S; Ge JQ; Wang ZH; Zhang Z
    Am J Infect Control; 2017 Nov; 45(11):e143-e147. PubMed ID: 28780198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marine bacteria and fungi as promising source for new antibiotics.
    Wiese J; Imhoff JF
    Drug Dev Res; 2019 Feb; 80(1):24-27. PubMed ID: 30370576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of 2,252 Pseudomonas aeruginosa Clinical Isolates Over 4 Years to 9 Antimicrobials in a Tertiary Greek Hospital.
    Maraki S; Mantadakis E; Nioti E; Samonis G
    Chemotherapy; 2014; 60(5-6):334-41. PubMed ID: 26302835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of antibiotic and antimicrobial biocide susceptibility data in clinical isolates of methicillin-sensitive Staphylococcus aureus, methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa between 1989 and 2000.
    Lambert RJ
    J Appl Microbiol; 2004; 97(4):699-711. PubMed ID: 15357719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Screening and identification of marine fungi against bacterial quorum sensing].
    Yin S; Chang Y; Deng S; Wang Q; Yu W; Gong Q
    Sheng Wu Gong Cheng Xue Bao; 2011 Sep; 27(9):1337-46. PubMed ID: 22117517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Status and Future Prospects of Marine Natural Products (MNPs) as Antimicrobials.
    Choudhary A; Naughton LM; Montánchez I; Dobson ADW; Rai DK
    Mar Drugs; 2017 Aug; 15(9):. PubMed ID: 28846659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approaches to antimicrobial discovery.
    Lewis K
    Biochem Pharmacol; 2017 Jun; 134():87-98. PubMed ID: 27823963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.